FDA Inspection 837531 — Reproductive Center Of Central New Jersey

Reproductive Center Of Central New Jersey — FEI 3006399783

The FDA completed an inspection of Reproductive Center Of Central New Jersey on Jun 24, 2013 in S Plainfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 24, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
S Plainfield, NJ (United States)

Citations

IDCFRDescription
1223621 CFR 1271.55(a)(2)Eligibility statement--basis of determination
1223721 CFR 1271.55(a)(3)Summary--records used to make determination
1227021 CFR 1271.65(a)Improper release prevention--storage, I.D.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.